Search Results - "Moati, Emilie"

Therapeutic Strategies for Patients with Advanced Small Bowel Adenocarcinoma: Current Knowledge and Perspectives by Moati, Emilie, Overman, Michael J, Zaanan, Aziz

“…Small bowel adenocarcinoma (SBA) is diagnosed at an advanced (unresectable or metastatic) tumor stage in approximately one-third of cases. This is partly due…”
Get full text

Plasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancer by Moati, Emilie, Blons, Hélène, Taly, Valerie, Garlan, Fanny, Wang‐Renault, Shu‐Fang, Pietrasz, Daniel, Didelot, Audrey, Garrigou, Sonia, Saint, Angélique, Pernot, Simon, Taieb, Julien, Laurent‐Puig, Pierre, Zaanan, Aziz

“…In metastatic colorectal cancer (mCRC), circulating tumor DNA (ctDNA) monitoring can be used to genotype tumors and track clonal evolution. We investigated the…”
Get full text

Response to systemic treatments in advanced fibrolamellar carcinoma: A French multicenter retrospective cohort of the AGEO by Ye-Tran, Xixi, Bouattour, Mohamed, Perret, Audrey, Turpin, Anthony, Walter, Thomas, Vitellius, Carole, Coriat, Romain, Lequoy, Marie, Blanc, Jean Frederic, Regnault, Hélène, Pietrasz, Daniel, Sefrioui, David, Lecomte, Thierry, Moati, Emilie, Caliez, Olivier, Nguyen-Khac, Eric, Fresneau, Brice, Hautefeuille, Vincent

“…e16194 Background: Fibrolamellar carcinomas (FLC) are rare hepatic malignancies affecting young patients without chronic liver disease, often diagnosed at an…”
Get full text

Ulcerative jejunitis secondary to Zollinger-Ellison syndrome following endoscopic ultrasound guided gastrojejunostomy by Pérez-Cuadrado-Robles, Enrique, Benosman, Hedi, Moati, Emilie, Cellier, Christophe, Rahmi, Gabriel

Get more information

Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives by Moati, Emilie, Taly, Valerie, Garinet, Simon, Didelot, Audrey, Taieb, Julien, Laurent-Puig, Pierre, Zaanan, Aziz

“…Gastrointestinal (GI) cancers are major health burdens worldwide and biomarkers are needed to improve the management of these diseases along their evolution…”
Get full text

Plasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancer by Moati, Emilie, Blons, Helene, Taly, Valerie, Garlan, Fanny, Wang-Renault, Shufang, Pietrasz, Daniel, Didelot, Audrey, Sonia, G., Saint, A., Pernot, S., Taieb, Julien, Laurent-Puig, Pierre, Zaanan, Aziz

Get full text

Ulcerative jejunitis secondary to Zollinger-Ellison syndrome following endoscopic ultrasound guided gastrojejunostomy by Pérez-Cuadrado-Robles, Enrique, Benosman, Hedi, Moati, Emilie, Cellier, Christophe, Rahmi, Gabriel

Get full text

Abstract PO4-13-06: Effect of neoadjuvant dose-dense dose-intense chemotherapy timing infusion on complete histological response rate among patients with triple negative breast cancer (SIMCLOCK) by Bouchez, Clementine, Catozzi, Simona, Cuvier, Caroline, Someil, Laetitia, De Bazelaire, Cedric, Miquel, Catherine, Mhamdi, Nozha, Teixeira, Luis, Espie, Marc, Moati, Emilie, Droin, Leonor, Ballesta, Annabelle, Giacchetti, Sylvie

“…Background: Triple-negative breast cancers (TNBC) exhibit major responses to dose-dense, dose-intense (DD-DI) neoadjuvant chemotherapy (NAC) (1). Although…”
Get full text

Maladie thromboembolique veineuse et cancer du sein by Crichi, Benjamin, Moati, Emilie, Cacciatore, Carlotta, Farge, Dominique, Frere, Corinne

“…Le cancer du sein est le cancer le plus fréquent chez la femme. Les patientes avec cancer du sein ont un risque de survenue de maladie thromboembolique…”
Get full text

Plasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancer: Plasma clearance of RAS mutation in colorectal cancer by Moati, Emilie, Blons, Hélène, Taly, Valérie, Garlan, Fanny, Wang‐renault, Shu‐fang, Pietrasz, Daniel, Didelot, Audrey, Garrigou, Sonia, Saint, Angélique, Pernot, Simon, Taïeb, Julien, Laurent‐puig, Pierre, Zaanan, Aziz

“…In metastatic colorectal cancer (mCRC), circulating tumor DNA (ctDNA) monitoring can be used to genotype tumors and track clonal evolution. We investigated the…”
Get full text

Role of circulating tumor DNA in the management of patients with colorectal cancer by Moati, Emilie, Taly, Valérie, Didelot, Audrey, Perkins, Géraldine, Blons, Hélène, Taieb, Julien, Laurent-Puig, Pierre, Zaanan, Aziz

“…Colorectal cancer is a major health burden with a prognosis that has been improved with the progresses in diagnosis and the advance of chemotherapy and…”
Get full text

La prise en charge des cancers du sein triple négatifs : état actuel et perspectives by Le Du, Fanny, Moati, Emilie, Vaflard, Pauline, Bailleux, Caroline, Pierga, Jean-Yves, Dieras, Véronique

Get full text

Gly388Arg FGFR4 Polymorphism Is Not Predictive of Everolimus Efficacy in Well-Differentiated Digestive Neuroendocrine Tumors by Cros, Jerome, Moati, Emilie, Raffenne, Jerome, Hentic, Olivia, Svrcek, Magali, de Mestier, Louis, Sbidian, Emilie, Guedj, Nathalie, Bedossa, Pierre, Paradis, Valerie, Sauvanet, Alain, Panis, Yves, Ruszniewski, Philippe, Couvelard, Anne, Hammel, Pascal

“…Preclinical data suggest that the single nucleotide polymorphism substituting a glycine for an arginine in codon 388 of the FGFR4 transmembrane domain may…”
Get more information

Gly388Arg FGFR4 polymorphism is not predictive of everolimus efficacy in well-differentiated digestive neuroendocrine tumors by Cros, Jerome, Moati, Emilie, Raffenne, Jerome, Hentic, Olivia, Svrcek, Magali, De Mestier, Louis, Sbidian, Emilie, Guedj, Nathalie, Bedossa, Pierre, Paradis, Valerie, Sauvanet, Alain, Panis, Yves, Ruszniewski, Philippe, Couvelard, Anne, Hammel, Pascal

“…[...]mTOR pathway molecules expression was not modified by the presence of at least one 388Arg allele…”
Get full text